The Valley Desk

NCT00786188 · Interventional trial

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause

Overall registry status Completed

Phase 2

Conditions Hot Flashes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov